NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England
key details
| Value | £3,185,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 +1 more |
| Deadline | 3 Sept 2021 |
| Contract start | 1 Jan 2022 |
| Contract end | 31 Mar 2024 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-c60280d9-a835-4dff-877a-3046d1b66e39 |
Awards (3)
This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £3,185,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Bayer Ltd shared | £3,185,000,000 | 15 Nov 2021 | active |
| Bristol Myers Squibb shared | £3,185,000,000 | 15 Nov 2021 | active |
| Daiichi Sankyo UK Ltd shared | £3,185,000,000 | 15 Nov 2021 | active |
description
NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).
Period of Framework: 01/01/2022 - 31/03/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 39 months)
documents
- https://www.contractsfinder.service.gov.uk/Notice/4aed5711-c38a-447d-bf8d-40c87c3a7788 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/bbec3a9a-168a-46c5-a71d-990c2a8a8212 , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 6 Aug 2021 | Tender (tender) | · | 4aed5711-c38a-447d-bf8d-40c87c3a7788-458697 |
| 25 Nov 2021 | Award (award) | · | 5725a1be-e7d8-4f2b-a152-221c6a2968d5-488946 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.